Differential musculoskeletal outcome reporting in patients receiving bempedoic acid or atorvastatin: a disproportionality analysis using the EudraVigilance database.
Saved in:
| Title: | Differential musculoskeletal outcome reporting in patients receiving bempedoic acid or atorvastatin: a disproportionality analysis using the EudraVigilance database. |
|---|---|
| Authors: | Gazzaniga G; Department of Medical Biotechnology and Translational Medicine, Postgraduate School of Clinical Pharmacology and Toxicology, University of Milano, Milano, Italy.; Department of General Surgery, Surgical Specialty and Anesthesiology, Sapienza University of Rome, Rome, Italy., Romio A; Department of Medical Biotechnology and Translational Medicine, Postgraduate School of Clinical Pharmacology and Toxicology, University of Milano, Milano, Italy., Galuppi C; Department of Medical Biotechnology and Translational Medicine, Postgraduate School of Clinical Pharmacology and Toxicology, University of Milano, Milano, Italy., Gentile E; Department of Medical Biotechnology and Translational Medicine, Postgraduate School of Clinical Pharmacology and Toxicology, University of Milano, Milano, Italy., Valentino F; Department of Medical Biotechnology and Translational Medicine, Postgraduate School of Clinical Pharmacology and Toxicology, University of Milano, Milano, Italy., De Toni L; Department of Medical Biotechnology and Translational Medicine, Postgraduate School of Clinical Pharmacology and Toxicology, University of Milano, Milano, Italy.; Unit of Andrology and Reproductive Medicine, Department of Medicine, University of Padova, Padova, Italy., Foschiatti M; Department of Medical Biotechnology and Translational Medicine, Postgraduate School of Clinical Pharmacology and Toxicology, University of Milano, Milano, Italy., Gringeri M; Department of Medical Biotechnology and Translational Medicine, Postgraduate School of Clinical Pharmacology and Toxicology, University of Milano, Milano, Italy., D'Onghia S; Department of Medical Biotechnology and Translational Medicine, Postgraduate School of Clinical Pharmacology and Toxicology, University of Milano, Milano, Italy., Menichelli D; Department of General Surgery, Surgical Specialty and Anesthesiology, Sapienza University of Rome, Rome, Italy., Pastori D; Department of Medical and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.; IRCCS Neuromed, Località Camerelle, Pozzilli, Isernia, Italy., Scatigna M; IRCCS Cardiologic Centre Monzino, Milan, Italy., Fornasari DMM; Department of Medical Biotechnology and Translational Medicine, University of Milano, Milano, Italy., Grosdani S; Department of Medical Biotechnology and Translational Medicine, Postgraduate School of Clinical Pharmacology and Toxicology, University of Milano, Milano, Italy., Pani A; Department of Oncology and Hematology-Oncology, University of Milano, Milano, Italy. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2026 Jan 22; Vol. 16, pp. 1736657. Date of Electronic Publication: 2026 Jan 22 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1663-9812 |
|---|---|
| DOI: | 10.3389/fphar.2025.1736657 |
